2016 Internatinal Meeting o the Molecular Biology of Hepatitis B Viruses
2016乙型肝炎病毒分子生物学国际会议
基本信息
- 批准号:9124150
- 负责人:
- 金额:$ 0.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-19 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnniversaryAntiviral AgentsAntiviral TherapyAsiaBasic ScienceBiochemistryBiologyBiomedical ResearchCellular biologyCessation of lifeCircular DNACirrhosisCommunitiesDevelopmentDiabetes MellitusDigestive System DisordersDiseaseEuropeFinancial SupportFoundationsFund RaisingFundingFutureGene ExpressionGoalsGrantHepatitis BHepatitis B VirusHepatitis CHepatitis Delta VirusHome environmentImmune responseImmunologyIndividualInfectionInstitutesInternationalInvestigationJointsKidney DiseasesKnowledgeKoreaLaboratoriesLettersLife Cycle StagesLightLiver FailureLiver diseasesMalignant NeoplasmsMissionModalityMolecular BiologyNational Cancer InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of General Medical SciencesNew YorkOralPathogenesisPharmacotherapyPopulationPostdoctoral FellowPrimary carcinoma of the liver cellsProcessPublic HealthRNA EditingRegulatory ElementRequest for ProposalsResearchResearch PersonnelScheduleSchemeScientistSenior ScientistSouth KoreaStructureSystemTherapeuticTimeTravelUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUniversitiesVaccinesViralVirusVirus DiseasesVirus ReceptorsVirus Sheddingbasecostgene therapygraduate studentinterestlecturesmeetingsminority investigatorpathogenpostersprogramsprophylacticprotein expressionpublic health relevancesymposiumvectorvirology
项目摘要
DESCRIPTION (provided by applicant): In this proposal, we request for funding to support the travel expenses for young scientists to attend and participate in the 2016 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 21st-24th, 2016 at the conference facility of the Yonsei University of Seoul, South Korea. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2014 meeting will uphold and enhance the traditional format. It will consist of 8 oral scientific sessions and 2 poster sessions as well as less structured "networking" time. The scientific interactions will be facilitated by two keynote addresses (see their acceptance letters). As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for supervising the meeting and publicizing it, especially to universitis with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested. It is expected that over 200-300 attendees will register for the 2016 HBV meeting, which will mark the 32nd anniversary of the HBV meeting.
描述(由申请人提供):在本提案中,我们请求资助年轻科学家参加 2016 年乙型肝炎病毒分子生物学国际会议的旅费,该会议定于 2016 年 9 月 21 日至 24 日在韩国首尔延世大学会议设施举行。这次会议是唯一一个聚集了国际研究人员的论坛,他们专注于乙型肝炎病毒(HBV)和密切相关的丁型肝炎病毒(HDV)。世界上大约25%的人口感染过乙型肝炎病毒。不幸的是,尽管有预防性疫苗,但世界范围内仍出现许多新感染,主要原因是由于成本和其他问题导致疫苗利用不足。此外,对于已经慢性感染乙肝病毒的大约3.5亿人(其中大约1500万同时感染丁肝病毒)来说,疫苗没有治疗价值。因此,全世界每年有 0.5 至 100 万人死于 HBV/HDV。因此,继续开展乙型肝炎的基础研究并及时讨论和传播该领域的最新进展势在必行。一年一度的乙型肝炎会议为科学交流和传播最新研究信息提供了论坛。 2014年的会议将秉承并加强传统的形式。它将包括 8 场口头科学会议和 2 场海报会议以及结构性较低的“社交”时间。两个主题演讲将促进科学互动(参见他们的录取通知书)。与过去一样,我们付出了巨大的努力来尽量减少会议的成本。此外,乙型肝炎基金会自 2005 年以来就坚定地承诺支持这次会议,为组织会议提供永久场所,并为其工作人员提供监督会议和宣传会议的机会,特别是针对拥有大量代表性不足的少数族裔的大学。为了让初级和少数族裔研究人员参与,需要 NIH 的支持来帮助支付会议费用。预计将有超过 200-300 名与会者注册参加 2016 年 HBV 会议,这将标志着 HBV 会议召开 32 周年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEEM SIDDIQUI其他文献
ALEEM SIDDIQUI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEEM SIDDIQUI', 18)}}的其他基金
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10092086 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10361391 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10569036 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8511268 - 财政年份:2013
- 资助金额:
$ 0.7万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8731176 - 财政年份:2013
- 资助金额:
$ 0.7万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




